^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    multi-epitope melanoma peptide

    i
    Associations
    News

    Trials

    Company:
    National Cancer Institute
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma (NCT00071981)
    Phase 2
    Eastern Cooperative Oncology Group
    Completed
    Last update posted :
    06/28/2023
    Initiation :
    05/09/2005
    Primary completion :
    08/01/2011
    Completion :
    01/01/2014
    IFNG • IL2
    |
    Leukine (sargramostim) • multi-epitope melanoma peptide